Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 15, 2011
Grant Date -
Jun 17, 2010
app pub date -
Mar 1, 2010
filing date -
Sep 25, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a method and a pharmaceutical composition for treatment of nerve disorders comprising administration of a therapeutically effective dosage of at least two substances selected from the group consisting of TNF inhibitors, IL-1 inhibitors, IL-6 inhibitors, IL-8 inhibitors, FAS inhibitors, FAS ligand inhibitors, and IFN-gamma inhibitors. Preferably, at least one of the substances is a TNF inhibitor.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully